Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DACLIZUMAB vs DALFAMPRIDINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DACLIZUMAB vs DALFAMPRIDINE: Safety Overview

Metric DACLIZUMAB DALFAMPRIDINE
Total FAERS Reports 2,801 56,141
Deaths Reported 193 1,482
Death Rate 6.9% 2.6%
Hospitalizations 835 7,813
Average Patient Age 45.7 yrs 55.9 yrs
% Female Patients 81.5% 73.8%
FDA Approval Date N/A Jan 22, 2010
Manufacturer N/A Accord Healthcare Inc.
Route N/A ORAL
Marketing Status Prescription Prescription